Response and Recurrence Correlates in Individuals Treated with Neoadjuvant Anti-Pd-1 Therapy for Resectable Oral Cavity Squamous Cell Carcinoma

Sixue Liu,Hannah M. Knochelmann,Shirley H. Lomeli,Aayoung Hong,Mary Richardson,Zhentao Yang,Raymond J. Lim, Yan Wang,Camelia Dumitras,Kostyantyn Krysan,Cynthia Timmers,Martin J. Romeo,Carsten Krieg,Elizabeth C. O'Quinn,Joshua D. Horton,Steve M. Dubinett,Chrystal M. Paulos,David M. Neskey,Roger S. Lo

Cell Reports Medicine（2021）

Cited 24|Views31

Key words

neoadjuvant anti-PD-1/L1 therapy,head-and-neck cancer/oral-cavity SCC,response, resistance, and recurrence,FLT4/PTEN/PPARG/CDKN2A/YAP1/JAK2,T cell repertoire,T regulatory to Th17 ratio,tumor mutational burden,recurrence-free survival,tumor phylogeny,multiplex immunofluorescence

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined